These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23662108)

  • 1. After the revolution? Ethical and social challenges in 'personalized genomic medicine'.
    Juengst ET; Settersten RA; Fishman JR; McGowan ML
    Per Med; 2012 Jun; 9(4):429-439. PubMed ID: 23662108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
    Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
    Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and personalized medicine: foundations and applications.
    Ginsburg GS; Willard HF
    Transl Res; 2009 Dec; 154(6):277-87. PubMed ID: 19931193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From "Personalized" to "Precision" Medicine: The Ethical and Social Implications of Rhetorical Reform in Genomic Medicine.
    Juengst E; McGowan ML; Fishman JR; Settersten RA
    Hastings Cent Rep; 2016 Sep; 46(5):21-33. PubMed ID: 27649826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized medicine: evidence of normativity in its quantitative definition of health.
    Vogt H; Hofmann B; Getz L
    Theor Med Bioeth; 2016 Oct; 37(5):401-16. PubMed ID: 27638683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking patient involvement seriously: a critical ethical analysis of participatory approaches in data-intensive medical research.
    Beier K; Schweda M; Schicktanz S
    BMC Med Inform Decis Mak; 2019 Apr; 19(1):90. PubMed ID: 31023321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
    McGowan ML; Settersten RA; Juengst ET; Fishman JR
    Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participatory medicine and patient empowerment towards personalized healthcare in multiple sclerosis.
    Lejbkowicz I; Caspi O; Miller A
    Expert Rev Neurother; 2012 Mar; 12(3):343-52. PubMed ID: 22364333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data as promise: Reconfiguring Danish public health through personalized medicine.
    Hoeyer K
    Soc Stud Sci; 2019 Aug; 49(4):531-555. PubMed ID: 31272287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory.
    Hood L; Flores M
    N Biotechnol; 2012 Sep; 29(6):613-24. PubMed ID: 22450380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Personalized medicine': what's in a name?
    Pokorska-Bocci A; Stewart A; Sagoo GS; Hall A; Kroese M; Burton H
    Per Med; 2014 Mar; 11(2):197-210. PubMed ID: 29751382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's in a word? The person of personalized (nano)medicine.
    Guchet X
    Nanomedicine (Lond); 2015; 10(20):3167-79. PubMed ID: 26446343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personal Genomes in Practice: Exploring Citizen and Healthcare Professionals' Perspectives on Personalized Genomic Medicine and Personal Health Data Spaces Using a Mixed-Methods Design.
    Tommel J; Kenis D; Lambrechts N; Brohet RM; Swysen J; Mollen L; Hoefmans MF; Pusparum M; Evers AWM; Ertaylan G; Roos M; Hens K; Houwink EJF
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of implementing personalized (precision) medicine: a focus on diabetes.
    Fodor A; Karnieli E
    Per Med; 2016 Sep; 13(5):485-497. PubMed ID: 29767596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bringing personalized medicine to the community through public engagement.
    Etchegary H; Wilson B
    Per Med; 2013 Sep; 10(7):647-659. PubMed ID: 29768762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Half a century of newborn screening in Spain: Evolution of ethical, legal and social issues (ELSIs). Part III, social issues.].
    Labrador Cañadas MV; Pàmpols Ros T; Dulín Íñiguez E; Pérez Aytés A; García Sagredo JM; Díaz de Bustamante A; Martín Arribas C; García López FJ; Nicolás Jiménez P
    Rev Esp Salud Publica; 2021 Jan; 95():. PubMed ID: 33496273
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.